Filter
1712
Filtered Results: 1712
Text search:
Africa
Centres
for
Disease
Control
and
Prevention
Center
for
Disease
Dynamics,
Economics
&
Policy
Featured
Recommendations
167
New Publications
432
Language
Document type
No document type
947
Studies & Reports
346
Guidelines
204
Manuals
99
Strategic & Response Plan
47
Fact sheets
25
Training Material
21
Situation Updates
17
Infographics
3
Resource Platforms
2
Online Courses
1
Countries / Regions
Liberia
67
Ethiopia
65
Africa
59
Global
57
Sierra Leone
52
Kenya
50
Nigeria
40
Rwanda
39
Tanzania
29
Uganda
28
India
27
Zambia
25
Malawi
25
Mozambique
22
Guinea
19
South Africa
19
Senegal
18
Congo, Democratic Republic of
18
Ghana
17
Latin America and the Carribbean
17
Nepal
15
Lesotho
15
Zimbabwe
13
West and Central Africa
13
Asia
13
Burkina Faso
12
Ukraine
12
Middle East and North Africa
12
Western and Central Europe
12
South Sudan
11
Namibia
11
Syria
10
Bangladesh
10
East and Southern Africa
10
Angola
9
Yemen
9
Cambodia
8
Eastern Europe
8
Philippines
7
Botswana
7
Cameroon
6
Eswatini/ Swaziland
6
South–East Asia Region
6
Haiti
5
Pakistan
5
Central African Republic
5
Brazil
5
Myanmar / Burma
5
Russia
5
Somalia
4
Thailand
4
Indonesia
4
Eastern Europe and Central Asia
4
Guinea-Bissau
3
Afghanistan
3
Benin
3
Albania
3
Mali
2
USA
2
Jordan
2
Germany
2
Turkey
2
China
2
Burundi
2
Libya
2
Madagascar
2
Sri Lanka
2
Armenia
2
Vietnam
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Malaysia
1
Papua New Guinea
1
Argentina
1
North Macedonia
1
Bolivia
1
Greece
1
Mexico
1
Chile
1
Western Pacific Region
1
Venezuela
1
Palestine
1
Italy
1
Southern Africa
1
Canada
1
Tajikistan
1
Qatar
1
Georgia
1
North America
1
Japan
1
Belgium
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
547
Clinical Guidelines
162
Public Health
107
Women & Child Health
82
Key Resources
72
Capacity Building
35
Pharmacy & Technologies
20
Toolboxes
HIV
182
COVID-19
152
TB
117
Mental Health
103
Ebola
95
AMR
88
Rapid Response
71
Planetary Health
67
NTDs
45
Caregiver
42
Disability
33
Global Health Education
33
NCDs
28
Refugee
25
Pharmacy
25
Conflict
24
Health Financing Toolbox
18
Zika
15
Natural Hazards
13
Cholera
12
Polio
6
Specific Hazards
5
Social Ethics
2
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre<...
This guidance note is meant to assist humanitarian actors, youth-led organizations, and young people themselves across sectors, working at local, country, regional, and global levels in their respon...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, ... associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large, growing, and underestimated
Disease Control Priorities –3rdEdition, Volume 2.
This book focuses on maternal conditions, childhood illness, and malnutrition. Specifically, t...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- ... middle-income countries (LMICs), where access to antibiotics has risen with increases in gross domestic product per capita. Per capita antibiotic consumption in LMICs is lower than in high-income countries, despite a higher infectious disease burden; however, consumption rates are rapidly converging. These trends reflect both better access to antibiotics for those who need them and increases in inappropriate antibiotic use.
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention ... control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health Organization (WHO) guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities relate to general measures (that is, the core components of infection prevention and control [IPC] programmes) that need to be in place in all countries and health care facilities to prevent and control health care-associated infections (HAIs). The use of a stepwise approach is proposed to support implementation and improvement, based on the evidence and experience of what has worked in several health care settings worldwide. The focus is on adoptable and adaptable information.
A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Vol.399 Issue 10341 p.2129-2154
Human resources for health (HRH) in...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of a...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prev... and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviours and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination.
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated ... severe infections are potentially curable as long as the aetiological agents are susceptible to the antimicrobial drugs. The rapid rate with which antimicrobial agents are becoming ineffective due to resistance acquired as a result of unchecked overuse and misuse threatens to undo the benefit of controlling infections. The evidence for resistant microorganisms, many times to more than a single antimicrobial agent, has been observed globally. In Tanzania, there is evidence in the form of few scattered studies conducted in different parts of the country in a multitude of settings including health care facilities, the community, domesticated animals and wild animals
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory ....
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging technology for better circulatory health and to capture the roles that various sectors have in making
digital health a tool for everyone.
The WHO country office for Ghana, began the year 2019 with a 4-day staff retreat at the Busua Beach Resort in the Western Region from 04 to 08 March 2019. The theme for the retreat was ‘Impacting ...
The number of COVID-19 cases is on the rise again, with South Africa nearing half of all confirmed cases in the WHO African Region. Threats of new variants loom and low vaccination coverage raises q...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) .../or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially in rural areas of low-income countries, making it difficult to identify and treat patients. Additionally, there is controversy about the role, type and duration of anthelmintic, antiinflammatory and antiepileptic drug (AED) treatments for different forms of neurocysticercosis.
These guidelines were developed to assist health-care providers in appropriate, evidence-based management of parenchymal neurocysticercosis. The guidelines do not address other forms of neurocysticercosis and do not include management of extraparenchymal disease (including cysticerci in the cerebral ventricles or subarachnoid space). The aim of the guidance is to improve decision-making to ensure appropriate patient care and to avoid misdiagnoses and inappropriate treatment of patients with neurocysticercosis.
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and mo...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be ...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was published in 2016 with the objective of improving the quality of routine health care that al...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exp...
